Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000972061 | SCV001119754 | likely benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002503082 | SCV002813712 | likely benign | Type I complement component 8 deficiency | 2022-04-25 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000972061 | SCV005257992 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000972061 | SCV001953143 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000972061 | SCV001973612 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003936139 | SCV004756351 | likely benign | C8A-related disorder | 2022-05-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |